申请人:NeuroSearch A/S
公开号:US20010018444A1
公开(公告)日:2001-08-30
Compounds of formula (a), (b), (c), or (d), or any mixture thereof, or a pharmaceutically-acceptable salt thereof;
1
wherein R is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl or 2-hydroxyethyl; R
3
is —CH
2
—X—R′, wherein X is O, S or NR″, wherein R″ is hydrogen or alkyl and R′ is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, or —CO-alkyl; R
4
is phenyl optionally substituted with halogen, CF
3
, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl; 3,4-methylenedioxyphenyl; benzyl optionally substituted with halogen, CF
3
, CH, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl; heteroaryl optionally substituted with halogen, CF
3
, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl; or naphthyl optionally substituted with halogen, CF
3
, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl. The compounds are monoamine neurotransmitter, i.e., dopamine, serotonin, noradrenaline, reuptake inhibitors.
化合物的化学式为(a)、(b)、(c)或(d),或者它们的任意混合物,或其药用盐;其中R为氢、烷基、烯基、炔基、环烷基、环烷烷基或2-羟乙基;R3为—CH2—X—R′,其中X为O、S或NR″,其中R″为氢或烷基,R′为烷基、烯基、炔基、环烷基、环烷烷基或—CO-烷基;R4为苯基,可选择地取代为卤素、CF3、CN、烷氧基、环烷氧基、烷基、环烷基、烯基、炔基、氨基、硝基、杂环烷基或芳基;3,4-亚甲二氧基苯基;苄基,可选择地取代为卤素、CF3、CH、烷氧基、环烷氧基、烷基、环烷基、烯基、炔基、氨基、硝基、杂环烷基或芳基;杂环烷基,可选择地取代为卤素、CF3、CN、烷氧基、环烷氧基、烷基、环烷基、烯基、炔基、氨基、硝基、杂环烷基或芳基;或萘基,可选择地取代为卤素、CF3、CN、烷氧基、环烷氧基、烷基、环烷基、烯基、炔基、氨基、硝基、杂环烷基或芳基。这些化合物是单胺类神经递质,即多巴胺、5-羟色胺、去甲肾上腺素的再摄取抑制剂。